Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.

Gibson CM, Levitan B, Gibson WJ, Yee MK, Murphy SA, Yuan Z, Chakrabarti AK, Lee M, Braunwald E.

J Am Coll Cardiol. 2018 Jul 10;72(2):129-136. doi: 10.1016/j.jacc.2018.04.055.

PMID:
29976285
2.

Pulmonary Artery Rupture Management with a Single Lumen Endotracheal Tube: Old Tricks that Should be Revisited.

Neerukonda T, Gibson WJ, Abicht T, Sauer A, Flynn BC.

Am J Case Rep. 2018 Mar 24;19:342-346.

3.

Erratum: Genomic landscape of high-grade meningiomas.

Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, A Ducar M, Thorner AR, van Hummelen P, O Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R.

NPJ Genom Med. 2017 Sep 4;2:26. doi: 10.1038/s41525-017-0023-6. eCollection 2017.

4.

Uniportal video-assisted thoracoscopic surgery (VATS) technique is associated with decreased narcotic usage over traditional VATS lobectomy.

Louis SG, Gibson WJ, King CL, Veeramachaneni NK.

J Vis Surg. 2017 Sep 14;3:117. doi: 10.21037/jovs.2017.08.05. eCollection 2017.

5.

Genomic landscape of high-grade meningiomas.

Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, Ducar M, Thorner AR, van Hummelen P, Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R.

NPJ Genom Med. 2017;2. pii: 15. doi: 10.1038/s41525-017-0014-7. Epub 2017 Apr 26. Erratum in: NPJ Genom Med. 2017 Sep 4;2:26.

6.

Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.

Holst F, Hoivik EA, Gibson WJ, Taylor-Weiner A, Schumacher SE, Asmann YW, Grossmann P, Trovik J, Necela BM, Thompson EA, Meyerson M, Beroukhim R, Salvesen HB, Cherniack AD.

Sci Rep. 2017 Jun 30;7:46873. doi: 10.1038/srep46873.

7.

Erratum: SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.

Zhang Y, Xie L, Gunasekar SK, Tong D, Mishra A, Gibson WJ, Wang C, Fidler T, Marthaler B, Klingelhutz A, Abel ED, Samuel I, Smith JK, Cao L, Sah R.

Nat Cell Biol. 2017 Jun 29;19(7):873. doi: 10.1038/ncb3556.

PMID:
28659636
8.

Erratum: SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.

Zhang Y, Xie L, Gunasekar SK, Tong D, Mishra A, Gibson WJ, Wang C, Fidler T, Marthaler B, Klingelhutz A, Abel ED, Samuel I, Smith JK, Cao L, Sah R.

Nat Cell Biol. 2017 May 31;19(6):740. doi: 10.1038/ncb3536. No abstract available.

PMID:
28561048
9.

SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.

Zhang Y, Xie L, Gunasekar SK, Tong D, Mishra A, Gibson WJ, Wang C, Fidler T, Marthaler B, Klingelhutz A, Abel ED, Samuel I, Smith JK, Cao L, Sah R.

Nat Cell Biol. 2017 May;19(5):504-517. doi: 10.1038/ncb3514. Epub 2017 Apr 24. Erratum in: Nat Cell Biol. 2017 Jun 29;19(7):873. Nat Cell Biol. 2017 May 31;19(6):740.

10.

Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.

Paolella BR, Gibson WJ, Urbanski LM, Alberta JA, Zack TI, Bandopadhayay P, Nichols CA, Agarwalla PK, Brown MS, Lamothe R, Yu Y, Choi PS, Obeng EA, Heckl D, Wei G, Wang B, Tsherniak A, Vazquez F, Weir BA, Root DE, Cowley GS, Buhrlage SJ, Stiles CD, Ebert BL, Hahn WC, Reed R, Beroukhim R.

Elife. 2017 Feb 8;6. pii: e23268. doi: 10.7554/eLife.23268.

11.

Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.

Gibson WJ, Ruan DT, Paulson VA, Barletta JA, Hanna GJ, Kraft S, Calles A, Nehs MA, Moore FD Jr, Taylor-Weiner A, Wala JA, Zack TI, Lee TC, Fennessy FM, Alexander EK, Thomas T, Janne PA, Garraway LA, Carter SL, Beroukhim R, Lorch JH, Van Allen EM.

Clin Cancer Res. 2017 May 1;23(9):2367-2373. doi: 10.1158/1078-0432.CCR-16-2154-T. Epub 2016 Oct 17.

12.

Landscape of Genomic Alterations in Pituitary Adenomas.

Bi WL, Horowitz P, Greenwald NF, Abedalthagafi M, Agarwalla PK, Gibson WJ, Mei Y, Schumacher SE, Ben-David U, Chevalier A, Carter S, Tiao G, Brastianos PK, Ligon AH, Ducar M, MacConaill L, Laws ER Jr, Santagata S, Beroukhim R, Dunn IF.

Clin Cancer Res. 2017 Apr 1;23(7):1841-1851. doi: 10.1158/1078-0432.CCR-16-0790. Epub 2016 Oct 5.

13.

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac Surgical Procedures.

Finger B, Brase J, He J, Gibson WJ, Wirtz K, Flynn BC.

Ann Thorac Surg. 2017 Jan;103(1):145-151. doi: 10.1016/j.athoracsur.2016.05.092. Epub 2016 Aug 21.

PMID:
27553502
14.

The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.

Gibson WJ, Hoivik EA, Halle MK, Taylor-Weiner A, Cherniack AD, Berg A, Holst F, Zack TI, Werner HM, Staby KM, Rosenberg M, Stefansson IM, Kusonmano K, Chevalier A, Mauland KK, Trovik J, Krakstad C, Giannakis M, Hodis E, Woie K, Bjorge L, Vintermyr OK, Wala JA, Lawrence MS, Getz G, Carter SL, Beroukhim R, Salvesen HB.

Nat Genet. 2016 Aug;48(8):848-55. doi: 10.1038/ng.3602. Epub 2016 Jun 27.

15.

Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.

Holst F, Hoivik EA, Gibson WJ, Taylor-Weiner A, Schumacher SE, Asmann YW, Grossmann P, Trovik J, Necela BM, Thompson EA, Meyerson M, Beroukhim R, Salvesen HB, Cherniack AD.

Sci Rep. 2016 Jun 24;6:27960. doi: 10.1038/srep27960. No abstract available.

16.

Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.

Holst F, Hoivik EA, Gibson WJ, Taylor-Weiner A, Schumacher SE, Asmann YW, Grossmann P, Trovik J, Necela BM, Thompson EA, Meyerson M, Beroukhim R, Salvesen HB, Cherniack AD.

Sci Rep. 2016 May 10;6:25521. doi: 10.1038/srep25521. Erratum in: Sci Rep. 2017 Jun 30;7:46873. Sci Rep. 2016 Jun 24;6:27960.

17.

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

Olenchock BA, Moslehi J, Baik AH, Davidson SM, Williams J, Gibson WJ, Chakraborty AA, Pierce KA, Miller CM, Hanse EA, Kelekar A, Sullivan LB, Wagers AJ, Clish CB, Vander Heiden MG, Kaelin WG Jr.

Cell. 2016 Apr 7;165(2):497. doi: 10.1016/j.cell.2016.03.037. No abstract available.

18.

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.

Olenchock BA, Moslehi J, Baik AH, Davidson SM, Williams J, Gibson WJ, Chakraborty AA, Pierce KA, Miller CM, Hanse EA, Kelekar A, Sullivan LB, Wagers AJ, Clish CB, Vander Heiden MG, Kaelin WG Jr.

Cell. 2016 Feb 25;164(5):884-95. doi: 10.1016/j.cell.2016.02.006. Erratum in: Cell. 2016 Apr 7;165(2):497.

19.

MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.

Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, Silva A, Boucher K, Henn RE, Kang YJ, Knoff D, Paolella BR, Gladden-Young A, Varlet P, Pages M, Horowitz PM, Federation A, Malkin H, Tracy AA, Seepo S, Ducar M, Van Hummelen P, Santi M, Buccoliero AM, Scagnet M, Bowers DC, Giannini C, Puget S, Hawkins C, Tabori U, Klekner A, Bognar L, Burger PC, Eberhart C, Rodriguez FJ, Hill DA, Mueller S, Haas-Kogan DA, Phillips JJ, Santagata S, Stiles CD, Bradner JE, Jabado N, Goren A, Grill J, Ligon AH, Goumnerova L, Waanders AJ, Storm PB, Kieran MW, Ligon KL, Beroukhim R, Resnick AC.

Nat Genet. 2016 Mar;48(3):273-82. doi: 10.1038/ng.3500. Epub 2016 Feb 1.

20.

ARID1A and TERT promoter mutations in dedifferentiated meningioma.

Abedalthagafi MS, Bi WL, Merrill PH, Gibson WJ, Rose MF, Du Z, Francis JM, Du R, Dunn IF, Ligon AH, Beroukhim R, Santagata S.

Cancer Genet. 2015 Jun;208(6):345-50. doi: 10.1016/j.cancergen.2015.03.005. Epub 2015 Mar 18.

21.

Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.

Berg A, Hoivik EA, Mjøs S, Holst F, Werner HM, Tangen IL, Taylor-Weiner A, Gibson WJ, Kusonmano K, Wik E, Trovik J, Halle MK, Øyan AM, Kalland KH, Cherniack AD, Beroukhim R, Stefansson I, Mills GB, Krakstad C, Salvesen HB.

Oncotarget. 2015 Jan 20;6(2):1327-39.

22.

BET bromodomain inhibition of MYC-amplified medulloblastoma.

Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ.

Clin Cancer Res. 2014 Feb 15;20(4):912-25. doi: 10.1158/1078-0432.CCR-13-2281. Epub 2013 Dec 2.

23.

Creation of photonic orbital angular momentum by distributed volume turbulence.

Oesch DW, Sanchez DJ, Gallegos AL, Holzman JM, Brennan TJ, Smith JC, Gibson WJ, Farrell TC, Kelly PR.

Opt Express. 2013 Mar 11;21(5):5440-55. doi: 10.1364/OE.21.005440.

PMID:
23482115
24.

Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis.

Franses JW, Drosu NC, Gibson WJ, Chitalia VC, Edelman ER.

Int J Cancer. 2013 Sep 15;133(6):1334-44. doi: 10.1002/ijc.28146. Epub 2013 Apr 8.

25.

Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance.

Baker AB, Gibson WJ, Kolachalama VB, Golomb M, Indolfi L, Spruell C, Zcharia E, Vlodavsky I, Edelman ER.

J Am Coll Cardiol. 2012 Apr 24;59(17):1551-60. doi: 10.1016/j.jacc.2011.11.057.

26.

Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.

Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, Coleman L, Wong GK, Edelman ER.

Circulation. 2011 Apr 5;123(13):1400-9. doi: 10.1161/CIRCULATIONAHA.110.003210. Epub 2011 Mar 21.

27.

Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

Kunadian V, Zorkun C, Williams SP, Biller LH, Palmer AM, Ogando KJ, Lew ME, Nethala N, Gibson WJ, Marble SJ, Buros JL, Gibson CM.

J Thromb Thrombolysis. 2008 Dec;26(3):234-42. doi: 10.1007/s11239-008-0276-0. Epub 2008 Sep 26. Review.

PMID:
18818881
28.

Transfusion associated microchimerism: a heretofore little-recognized complication following transfusion.

Kunadian V, Zorkun C, Gibson WJ, Nethala N, Harrigan C, Palmer AM, Ogando KJ, Biller LH, Lord EE, Williams SP, Lew ME, Ciaglo LN, Buros JL, Marble SJ, Gibson CM.

J Thromb Thrombolysis. 2009 Jan;27(1):57-67. doi: 10.1007/s11239-008-0268-0. Epub 2008 Sep 3. Review.

PMID:
18766299
29.

Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.

Kunadian V, Harrigan C, Zorkun C, Palmer AM, Ogando KJ, Biller LH, Lord EE, Williams SP, Lew ME, Ciaglo LN, Buros JL, Marble SJ, Gibson WJ, Gibson CM.

J Thromb Thrombolysis. 2009 Apr;27(3):316-28. doi: 10.1007/s11239-008-0220-3. Epub 2008 Apr 20. Review.

PMID:
18425623
30.

Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.

Olenchock SA Jr, Karmpaliotis D, Gibson WJ, Murphy SA, Southard MC, Ciaglo L, Buros J, Mack MJ, Alexander JH, Harrington RA, Califf RM, Kouchoukos NT, Ferguson TB Jr, Gibson CM.

Ann Thorac Surg. 2008 Feb;85(2):520-4. doi: 10.1016/j.athoracsur.2007.10.061.

PMID:
18222256
31.
32.

Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction.

Gibson CM, Gibson WJ, Murphy SA, Marble SJ, McCabe CH, Turakhia MP, Kirtane AJ, Karha J, Aroesty JM, Giugliano RP, Antman EM; TIMI Study Group.

Am J Cardiol. 2003 Sep 1;92(5):595-7.

PMID:
12943884
33.
35.
36.
37.

The relationship of fibrocystic disease to breast carcinoma.

Gibson WJ Jr.

J Miss State Med Assoc. 1988 May;29(5):137-9. No abstract available.

PMID:
2838637
38.

Proceedings: Experimental evaluation of coronary infusates in dogs.

Gibson WJ, Heath BJ, Lockard V, Raju S, Hardy JD.

J Cardiovasc Surg (Torino). 1976 Jan-Feb;17(1):89. No abstract available.

PMID:
1245523
39.

Early structural changes in mitochondria in response to acute reductions in capillary flow.

Antonenko DR, Gibson WJ.

Adv Exp Med Biol. 1976;75:165-70. No abstract available.

PMID:
1015401
40.

Experimental evaluation of coronary infusates in dogs.

Raju S, Gibson WJ, Heath B, Lockhart V, Conn H.

Arch Surg. 1975 Nov;110(11):1374-82.

PMID:
1191032
41.

Medical survey of students in Segbwema, Sierre Leone.

Gibson WJ, Gibson N, Lord S.

Trop Doct. 1974 Apr;4(2):76-80. No abstract available.

PMID:
4820546
42.

Hypernasality, bony and soft tissue relationships.

Maran AG, Gibb AG, Gibson WJ, Asbury DL.

J Laryngol Otol. 1971 Feb;85(2):105-11. No abstract available.

PMID:
5548875
43.

Craniometaphyseal dysplasia congenita--Pyle's disease in a young child.

Girdwood TG, Gibson WJ, Mackintosh TF.

Br J Radiol. 1969 Apr;42(496):299-303. No abstract available.

PMID:
5776408
44.

Therapy of multiple injuries.

Gibson WJ.

Manit Med Rev. 1969 Feb;49(2):50-1. No abstract available.

PMID:
5775169
45.

The eye and whiplash injuries.

Gibson WJ.

J Fla Med Assoc. 1968 Oct;55(10):917-8. No abstract available.

PMID:
5725000
46.

The influence of pancreatic duct ligation on the course of E. coli endotoxin shock in the dog.

De Koos EB, Gibson WJ, Bounous G, Hampson LG.

Can J Surg. 1966 Jul;9(3):227-30. No abstract available.

PMID:
5328814
47.

The value of a clinical shock study protocol in the management of refractory shock.

Gurd FN, Hampson LG, Gibson WJ, Innes BJ, Mulder DS.

J Trauma. 1966 Mar;6(2):157-75. No abstract available.

PMID:
5908170
48.

Glaucoma for the general practitioner.

GIBSON WJ.

J Fla Med Assoc. 1958 Jun;44(12):1334-6. No abstract available.

PMID:
13539350
49.

The mirror of the eye.

GIBSON WJ.

J Fla Med Assoc. 1956 Jan;42(7):560-2. No abstract available.

PMID:
13278466

Supplemental Content

Loading ...
Support Center